Navigation Links
Novel Vaccine Approach Offers Hope in Fight Against HIV
Date:5/17/2009

--Gene Transfer Technology May Lead to an HIV Vaccine--

PHILADELPHIA, May 17 /PRNewswire-USNewswire/ -- A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers. By using gene transfer technology that produces molecules that block infection, the scientists protected monkeys from infection by a virus closely related to HIV -- the simian immunodeficiency virus, or SIV -- that causes AIDS in rhesus monkeys.

"We used a leapfrog strategy, bypassing the natural immune system response that was the target of all previous HIV and SIV vaccine candidates," said study leader Philip R. Johnson, M.D., chief scientific officer at The Children's Hospital of Philadelphia. Johnson developed the novel approach over a ten-year period, collaborating with K. Reed Clark, Ph.D., a molecular virologist at Nationwide Children's Hospital in Columbus, Ohio.

The study appeared today in the online version of Nature Medicine.

Johnson cautioned that many hurdles remain before the technique used in this animal study might be translated into an HIV vaccine for humans. If the technique leads to an effective HIV vaccine, such a vaccine may be years away from realization.

Most attempts at developing an HIV vaccine have used substances aimed at stimulating the body's immune system to produce antibodies or killer cells that would eliminate the virus before or after it infected cells in the body. However, clinical trials have been disappointing. HIV vaccines have not elicited protective immune responses, just as the body fails on its own to produce an effective response against HIV during natural HIV infection.

The approach taken in the current study was divided into two phases. In the first phase, the research team created antibody-like proteins (call
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials
2. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
3. VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis
4. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
7. Worldwide Sensation: "A"- Implant Novelty From Austria
8. Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology
9. Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
10. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
11. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015 Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, today announced that ... ring The Opening Bell ® of the New ... Asterias began trading as an NYSE MKT listed company ... Stock Exchange is a trusted partner to Asterias Biotherapeutics, ...
(Date:3/4/2015)... March 4, 2015  NxStage Medical, Inc. (Nasdaq: ... announced that Jeffrey H. Burbank , Chief Executive Officer, ... Miami, FL on Wednesday, March 11 ... of the event will be made available at http://ir.nxstage.com ... About NxStage NxStage Medical, Inc. (Nasdaq: ...
(Date:3/4/2015)... , March 4, 2015  Mail-service and ... consumers, employers and government health plans $11.8 ... released by the Pharmaceutical Care Management Association (PCMA). ... drugs offers one of the easiest ways to ... Mark Merritt . "Policymakers should resist efforts ...
Breaking Medicine Technology:Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 2Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 3NxStage to Present at the Barclays Capital Global Healthcare Conference 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2
... Inc. (Nasdaq: ALXA ) today announced positive ... (Staccato(R) zaleplon). AZ-007 is an,inhalation product candidate being ... difficulty falling asleep, including patients who awake,in the ... back asleep., "This is the fifth product ...
... be presented as late-breaking data at EuroPCR ... XTENT, Inc.,(Nasdaq: XTNT ) today reported financial results for the ... loss of $12.5 million, or $0.54 per share,for the first quarter ... per share, for the first quarter of 2007. The company,s net ...
Cached Medicine Technology:Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon) 2Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon) 3Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon) 4XTENT Announces First Quarter 2008 Financial Results 2XTENT Announces First Quarter 2008 Financial Results 3XTENT Announces First Quarter 2008 Financial Results 4XTENT Announces First Quarter 2008 Financial Results 5
(Date:3/4/2015)... NH (PRWEB) March 04, 2015 ... natural frozen food category, will attend this year’s Natural ... its newest product line. With this new line, Blake’s, ... in the natural channel, continues its commitment to creating ... fastest growing frozen brand in the natural channel, Blake’s ...
(Date:3/4/2015)... The print component of “Organic Living” is ... with a circulation of approximately 173,000 copies and an ... distributed nationally through a vast social media strategy and ... outlets. To explore the digital version of the campaign, ... of heat-dried microbes that have digested the organic material ...
(Date:3/4/2015)... CA (PRWEB) March 04, 2015 The ... dialogue and lyrical music, will be performed by the ... Hills Estates, CA, this March 6-22, 2015, on Fridays, ... Center at Peninsula High School (27118 Silver Spur ... one hour before the program or may be purchased ...
(Date:3/4/2015)... 2015 Columbus is no stranger to drug ... cocaine addiction, and suffers from the potential threat of ... 27th, the DEA revealed that Kratom is a “drug of ... the newly introduced herb from Southeast Asia acts as a ... WKYC notes kratom foments symptoms similar to heroin withdrawal, and ...
(Date:3/4/2015)... The Alliance for Regenerative Medicine ... upcoming fifth annual Advanced Therapies Summit next Thursday, ... this year will feature five expert-led interactive roundtables ... field’s leading companies and organizations. , This ... clinical researchers from the advanced therapies community across ...
Breaking Medicine News(10 mins):Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 2Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 3Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3
... President Barak Obama speaks to the American Medical Association (AMA) ... nation, including physicians from coast to coast, is listening. ... AMA will not support a public health insurance, option. Since ... taking an anti-public insurance stance, the AMA is fostering the ...
... PF Advocate, and Top PF Researcher and Clinician , , ... today announced its co-founder and other Pulmonary Fibrosis (PF) experts will ... Radio" on Tuesday, June 16th from 6-7 a.m. EDT. For ... a free pass available on the Internet. , ...
... but there are potential risks , MONDAY, June 15 (HealthDay ... the purported cholesterol-lowering effects of the centuries-old natural product called ... a yeast, Monascus purpureus , is grown on rice. ... a thousand years as food and medicine. In the United ...
... , Experts from Northwestern Memorial,s Bluhm Cardiovascular Institute open their ... and surgery , , CHICAGO, June 15 ... looking forward to their senior year of high school. Though ... part of the Cardiology Summer Academy (CSA) at Northwestern Memorial ...
... not help others with mild memory loss, study finds, ... increase the chance of developing Alzheimer,s disease among those ... But the drug donepezil (Aricept), commonly prescribed for people ... the disease, the study also found. , The findings ...
... , , WAYNE, Pa., June 15 ... best spine products, engineering teams and inventors for 2009. ... exclusively on rewarding excellence and innovation. , , ... for Cervical Care, Lumbar Care, Motion Preservation of the ...
Cached Medicine News:Health News:Indiana U. expert says nation's physicians support national health insurance 2Health News:CPF, Pulmonary Fibrosis Experts Guests on Sirius and XM Satellite Radio Show June 16th 2Health News:A Substitute for Those Who Can't Take Statins? 2Health News:A Substitute for Those Who Can't Take Statins? 3Health News:Teens as Cardiologists in Training: Program Swaps Backpacks for Stethoscopes 2Health News:Teens as Cardiologists in Training: Program Swaps Backpacks for Stethoscopes 3Health News:Teens as Cardiologists in Training: Program Swaps Backpacks for Stethoscopes 4Health News:Drug May Stem Slide Into Alzheimer's for Some 2Health News:First Spine Technology Awards to Recognize Excellence and Innovation 2
Small curved rounded blade. Flat serrated handle with polished finish....
For use with E0828 needle and gouge set and E0828 C handle. Triangular shape curved 5.0 mm blade. Polished finish. Most popular size or model....
Set consists of one each:E0824 A replacement burr set. E0824 B handle....
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle....
Medicine Products: